"COVID-19和脂肪肝疾病"是一项研究
Maria Guarino1, Valentina Cossiga1, Francesco Maria Cutolo1
1Diseases of the Liver and Biliary System Unit, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.
COVID-19大流行严重影响脂肪肝疾病 (FLD) 患者,增加严重疾病的风险. 本综述探讨了流行病期间FLD患者的分子联系,临床结果和管理策略,包括远程医疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 随着COVID-19的蔓延,人们普遍患上疾病,特别是那些患有肥胖,糖尿病和肝脏疾病等代谢疾病的人.
- 非酒精性脂肪性肝病 (NAFLD) 是慢性肝病 (CLD) 的普遍原因,与COVID-19患者群体形成了显著的重叠.
研究的目的:
- 分析COVID-19和脂肪肝疾病 (FLD) 之间的关系.
- 确定FLD患者中严重COVID-19的分子机制和临床预测因素.
- 检查在流行病期间FLD管理的变化,强调远程医疗和预防性干预.
主要方法:
- 文献综述侧重于分子机制,临床演示和管理策略.
- 分析SARS-CoV-2感染与脂肪肝疾病频谱之间的相互作用.
- 探讨远程医疗在卫生危机期间管理FLD中的作用.
主要成果:
- 代谢性并发症,包括FLD,与COVID-19严重程度的增加有关.
- 特定的分子通路将SARS-CoV-2感染与肝损伤和代谢功能障碍联系起来.
- 远程医疗已经成为在疫情期间管理FLD患者的关键工具.
结论:
- 在COVID-19期间,FLD患者面临更高的风险,因此需要量身定制的管理策略.
- 了解COVID-19对肝脏影响的分子基础对于开发有效治疗方法至关重要.
- 调整医疗保健提供,例如通过远程医疗,对于在流行病期间支持弱势患者群体至关重要.
更多相关视频
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:12Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
相关概念视频
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
